Related Experiment Video
Updated: Jul 12, 2025
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.5K
Preventing new-onset heart failure: Intervening at stage A
Bharathi Upadhya1, Shriram Hegde2, Manasi Tannu1
1Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
American Journal of Preventive Cardiology
|October 25, 2023
Summary
Preventing heart failure (HF) in Stage A patients requires early risk factor awareness and lifestyle changes. Comprehensive strategies, including managing blood pressure, diabetes, and lipids, are crucial for primordial HF prevention.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Heart failure (HF) prevention is a critical public health issue.
- Stage A HF patients lack symptoms but face HF development risk.
- Current detection strategies for Stage A patients are insufficient.
Purpose of the Study:
- To highlight the need for comprehensive strategies for Stage A HF prevention.
- To emphasize early risk factor identification and intervention.
- To advocate for primordial and primary HF prevention strategies.
Main Methods:
- Review of current HF prevention guidelines and risk factors.
- Identification of Stage A HF patient heterogeneity and risk stratification needs.
- Discussion of comprehensive prevention strategies including lifestyle and medical management.
Main Results:
- Stage A patients are diverse with varying HF risks.
- Intensive blood pressure, glycemic, and lipid management are key.
- Heart-healthy behaviors (Life's Essential 8) are vital.
- Nontraditional risk factors (e.g., CKD, AFib, genetic susceptibility) increase HF risk.
- Biomarkers, imaging, and echocardiography can enhance risk prediction.
Conclusions:
- Public awareness of HF risk factors and early healthy lifestyle choices are paramount.
- Recognizing HF risk-enhancing factors is essential for early intervention.
- Policies must extend beyond secondary prevention to encompass primordial and primary HF prevention.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:30Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:30Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
01:28Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40